CHEMOTHERAPY OF LEISHMANIASIS AND TRYPANOSOMIASIS - ADVANCES AND FAILURES

Major advances have been made in the treatment of visceral leishmanias is. Studies on efficacy, tolerability and dosages have been completed during the past year for a number of new drugs, mainly lipidic formula tions of amphotericin B. No significant progress has, however, been ma de in the chemotherapy of trypanosomiasis, for which more effective an d less toxic drugs are urgently needed.